DRUG

Panitumumab

1 hypothesis across 1 therapeutic domain

ALL HYPOTHESES

Repurposing candidates for Panitumumab

Pancreatic cancer 1

Mediator Outcome Score Tier Lit. status Trial
EGFR pancreatic ductal adenocarcinoma 0.208 Mid partial evidence active

Clinical trials

200 registered trials for Panitumumab

Source: ClinicalTrials.gov

← All drugs